目的:探究miR-23a-3p在肺结核(PTB)患者中的表达及其对PTB患者的诊断和预后的价值。方法:将2020年6月至2021年6月本院传染病科收治的98例PTB患者设为PTB组,同期另选取92例健康志愿者作为健康组。采用qRT-PCR法检测受试者外周血miR-23a-3p、核转录因子SP1(SP1)和干扰素调节因子1(IRF1)的表达;绘制受试者工作特征(ROC)曲线分析miR-23a-3p对PTB的诊断价值和预后价值;采用Pearson相关系数分析PTB患者外周血miR-23a-3p与SP1、IPF1之间的相关性;对PTB患者完成6个月随访,采用Kaplan-Meier法分析miR-23a-3p与PTB患者预后关系;Cox回归分析影响PTB患者预后的危险因素。结果:与健康组相比,PTB组患者miR-23a-3p水平显著降低,SP1和IPF1表达显著升高(P<0.05);ROC曲线显示,外周血miR-23a-3p诊断PTB的曲线下面积(AUC)为 0.861(95%CI:0.809~0.913),灵敏度和特异度分别为85.70%和70.70%;Pearson相关系数分析显示,PTB患者外周血miR-23a-3p的表达与SP1表达和IPF1表达均呈负相关(r值分别为-0.570、-0.435,均P＜0.05),PTB患者SP1表达与IPF1表达呈正相关(r=0.524,P＜0.05);随访期间,患者预后良好87例,预后不良11例;ROC曲线显示,miR-23a-3p预测PTB患者预后的AUC为 0.881(95%CI:0.790~0.971),灵敏度和特异度分别为72.70%和92.00%;与预后良好组相比,预后不良组miR-23a-3p水平显著降低,SP1和IPF1表达显著升高(P<0.05);Kaplan-Meier分析结果显示,miR-23a-3p高表达PTB患者复发率明显低于miR-23a-3p低表达患者;Cox回归分析显示,肺部空洞、痰液MTB培养阳性、miR-23a-3p低表达、SP1高表达、IPF1高表达是影响PTB患者预后的危险因素。结论:PTB患者外周血miR-23a-3p表达明显降低,其低表达是影响PTB患者预后的危险因素,对PTB诊断和预后判断均具有良好的价值。 |
Objective: To explore the expression of miR-23a-3p in pulmonary tuberculosis(PTB) patients and its value in the diagnosis and prognosis of PTB patients. Methods: From June 2020 to June 2021, 98 patients with PTB who were admitted to the Department of Infectious Diseases of our hospital were gathered as PTB group, and 92 healthy volunteers were gathered into healthy group. qRT-PCR method was applied to detect the expressions of miR-23a-3p, nuclear transcription factor SP1(SP1) and interferon regulatory factor 1(IRF1) in peripheral blood of the subjects.Receiver operating characteristic(ROC) curve was drawn to analyze the diagnostic value of miR-23a-3p for PTB. Pearson's method was applied to analyze the correlation between miR-23a-3p and SP1 and IPF1 in peripheral blood of the PTB patients.Completion of 6-month follow-up for the PTB patients, Kaplan-Meier method was applied to analyze the relationship between miR-23a-3p and the prognosis of the PTB patients. Cox regression was applied to analyze risk factors affecting the prognosis of the PTB patients. Results: Compared with the healthy group, the miR-23a-3p in the PTB group was obviously decreased, and the expressions of SP1 and IPF1 were obviously increased(P<0.05).The ROC curve showed that the area under the curve(AUC) of peripheral blood miR-23a-3p for the diagnosis of PTB was 0.861(95%CI:0.809-0.913), and the sensitivity and specificity were 85.70% and 70.70%, respectively.The correlation analysis by Pearson method showed that the expression of miR-23a-3p in peripheral blood of the PTB patients was negatively correlated with the expression of SP1 and IPF1(r=-0.570, P<0.05; r=-0.435, P<0.05), the expression of SP1 in peripheral blood of the PTB patients was positively correlated with the expression of IPF1(r=0.524, P<0.05).During the follow-up period of the patients, 87 cases had good prognosis and 11 cases had poor prognosis.The ROC curve showed that the AUC of miR-23a-3p to predict the prognosis of PTB patients was 0.881(95%CI:0.790-0.971), and the sensitivity and specificity were 72.70% and 92.00%, respectively.Compared with the good prognosis group, the miR-23a-3p in the poor prognosis group was obviously decreased, and the expressions of SP1 and IPF1 were obviously increased(P<0.05). Kaplan-Meier analysis showed that the recurrence rate of the PTB patients with high miR-23a-3p expression was obviously lower than that of the patients with low miR-23a-3p expression. Cox regression analysis showed that lung cavity, positive sputum MTB culture, low expression of miR-23a-3p, high expression of SP1, and high expression of IPF1 were risk factors affecting the prognosis of patients with PTB. Conclusion: The expression of miR-23a-3p in peripheral blood of patients with PTB is obviously decreased, and its low expression is a risk factor affecting the prognosis of the patients with PTB, and it has good value for the diagnosis and prognosis of PTB. |
[1] 李向蓉.肺结核流行病学特征与发病趋势预测及延误治疗的危险因素[J].现代医学,2022,50(4):471-475.
[2] ZHU Y,JIA H,CHEN J,et al.Decreased osteopontin expression as a reliable prognostic indicator of improvement in pulmonary tuberculosis:impact of the level of interferon-gamma-Inducible protein 10[J].Cell Physiol Biochem,2015,37(5):1983-1996.
[3] KORMA W,MIHRET A,TAREKEGN A,et al.Identification of circulating miR-22-3p and miR-93-5p as stable endogenous control in tuberculosis study[J].Diagnostics(Basel),2020,10(11):868-881.
[4] SUN W,ZHANG X,HE X,et al.Long non-coding RNA SNHG16 silencing inhibits proliferation and inflammation in mycobacterium tuberculosis-infected macrophages by targeting miR-140-5p expression[J].Infect Genet Evol,2022,103:105325-105333.
[5] CHEN Y C,LEE C P,HSIAO C C,et al.MicroRNA-23a-3p down-regulation in active pulmonary tuberculosis patients with high bacterial burden inhibits mononuclear cell function and phagocytosis through TLR4/TNF-α/TGF-β1/IL-10 ssignaling via targeting IRF1/SP1[J].Int J Mol Sci,2020,21(22):8587-8604.
[6] CAI H A,HUANG L,ZHENG L J,et al.Ginsenoside(Rg-1) promoted the wound closure of diabetic foot ulcer through iNOS elevation via miR-23a/IRF-1 axis[J].Life Sci,2019,233:116525-116535.
[7] LI Z,LI C,BAO R,et al.Expressions of miR-29a,TNF-α and vascular endothelial growth factor in peripheral blood of pulmonary tuberculosis patients and their clinical significance[J].Iran J Public Health,2020,49(9):1683-1691.
[8] AI L,FENG P,CHEN D,et al.Clinical value of interferon-γ release assay in the diagnosis of active tuberculosis[J].Exp Ther Med,2019,18(2):1253-1257.
[9] WANG C,YANG S,LIU C M,et al.Screening and identification of four serum miRNAs as novel potential biomarkers for cured pulmonary tuberculosis[J].Tuberculosis(Edinb),2018,108:26-34.
[10] FATHIZADEH H,HAYAT S M G,DAO S,et al.Long non-coding RNA molecules in tuberculosis[J].Int J Biol Macromol,2020,156:340-346.
[11] GAO S H,CHEN C G,ZHUANG C B,et al.Integrating serum microRNAs and electronic health records improved the diagnosis of tuberculosis[J].J Clin Lab Anal,2021,35(8):23871-23879.
[12] 桃卓嫣,吴伟东,古佳升.血清外泌体microRNAs联合检测在食管癌早期诊断中的价值[J].现代医学,2022,50(2):187-191.
[13] HUA Y,SUN F Y,WU Y H,et al.MicroRNA-155 from sputum as noninvasive biomarker for diagnosis of active pulmonary tuberculosis[J].Iran J Basic Med Sci,2020,23(11):1419-1425.
[14] KALAY C I,YüKSEK F,KIG C,et al.Association between active pulmonary tuberculosis and circulating microRNAs:a preliminary study from Turkey[J].Turk J Med Sci,2021,51(4):1894-1904.
[15] HUANG Z,YAO F,LIU J,et al.Up-regulation of circRNA-0003528 promotes mycobacterium tuberculosis associated macrophage polarization via down-regulating miR-224-5p,miR-324-5p and miR-488-5p and up-regulating CTLA4[J].Aging(Albany NY),2020,12(24):25658-25672.
[16] SUN Q,WANG B,LI M.MicroRNA-23a-3p targeting of HMGB1 inhibits LPS-induced inflammation in murine macrophages in vitro[J].Exp Ther Med,2022,23(5):322-331.
[17] KUMAR N P,MOIDEEN K,NANCY A,et al.Acute phase proteins are baseline predictors of tuberculosis treatment failure[J].Front Immunol,2021,12:731878-731885.
[18] 黎志钦,刘永达.肾癌患者血清miR-23a-3p、miR-29a表达变化及临床意义[J].山东医药,2021,61(28):58-61.
[19] GE Q M,HUANG C M,ZHU X Y,et al.Differentially expressed miRNAs in sepsis-induced acute kidney injury target oxidative stress and mitochondrial dysfunction pathways[J].PLoS One,2017,12(3):e0173292-e0173311.
[20] ZHANG P,LIU L,YAO L,et al.Improved differentiation ability and therapeutic effect of miR-23a-3p expressing bonemarrow-derived,esenchymal stem cells in mice model with acute lung injury[J].Int J Stem Cells,2021,14(2):229-239.
[21] WU L,CHENG Q,WEN Z,et al.IRF1 as a potential biomarker in Mycobacterium tuberculosis infection[J].J Cell Mol Med,2021,25(15):7270-7279.
[22] ZHANG W,ZHANG S,WANG Z.Prognostic value of 12 m7G methylation-related miRNA markers and their correlation with immune infiltration in breast cancer[J].Front Oncol,2022,12:929363-929378. |
